Patent US2727278A successfully refreshed from Google Patents.
← Back to Patent Explorer
US6087325A Expired / Lapsed US ⏱️ 0.0 years remaining

Peptide-lipid conjugates

Assignee: Elan Pharmaceuticals LLC
•
Filing: 1997-10-15
•
Granted: 2000-07-11
•
Expires: 2017-10-15
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract Peptide-lipid conjugates are incorporated into liposomes so as to selectively destabilize the liposomes in the vicinity of target peptidase-secreting cells, and hence, to deliver the liposomes to the vicinity of the target cells, or directly into the cells. The liposomes can thus be used to treat mammals for diseases, disorders or conditions, e.g., tumors, microbial infection and inflammations, characterized by the occurrence of peptidase-secreting cells.

Inventors

  • 👤 Paul R. Meers
  • 👤 Charles Pak
  • 👤 Shaukat Ali
  • 👤 Andrew Janoff
  • 👤 J. Craig Franklin
  • 👤 Ravi K. Erukulla
  • 👤 Donna Cabral-Lilly

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-10-23 12:42
CPC Classifications
C; C07; C07K; C07K7/00; C07K7/04; C07K7/06; A; A61; A61K; A61K47/00; A61K47/50; A61K47/51; A61K47/54; A61K47/543; A61K47/544; A61K47/62; A61K47/69; A61K47/6905; A61K47/6911; A61K9/00; A61K9/10; A61K9/127; A61K9/1271; A61K9/1272; C07K1/00; C07K1/107; C07K1/1072; C07K1/1077; C07K5/00; C07K5/04; C07K5/06; C07K5/06008; C07K5/06017; C07K5/06026; C07K5/06191; C07K5/08; C07K5/0802; C07K5/0804; C07K5/0806; C07K5/0808; C07K5/0819; C07K5/0821; C07K5/0823; C07K5/0827; C07K5/10; C07K5/1002; C07K5/1005; C07K5/1008; C07K5/1013; C07K5/1027; C07K9/00; C07K9/001; A61K38/00

Claims Analysis

Total Claims: 13
Claim 1
Independent Claim 199 words
A peptide-lipid conjugate having the formula: ##STR6## wherein: X is a linker selected from the group consisting of a single bond and the group R 3 ; each of R 1 , R 2 and R 3 is --OC(O)(CH 2 ) n1 (CH═CH) n2 (CH 2 ) n3 (CH═CH) n4 (CH 2 ) n5 (CH═CH) n6 (CH 2 ) n7 (CH═CH) n8 (CH 2 ) n9 CH 3 ; n1 is zero or an integer equal to from 1 to 22, n3 is zero or an integer equal to from 1 to 19, n5 is zero or an integer equal to from 1 to 16, n7 is zero or an integer equal to from 1 to 13, n9 is zero or an integer equal to from 1 to 10; for each of R 1 and R 2 the sum of n1+2n2+n3+2n4+n5+2n6+n7+2n8+n9 is an integer equal to from 12 to 22; for R 3 the sum of n1+2n2+n3+2n4+n5+2n6+n7+2n8+n9 is an integer equal to from 0 to 22, each of n2, n4, n6 and n8 is equal to 0 or 1; and, Y is an enzyme cleavable peptide comprising an amino acid sequence which is the substrate of a cell-secreted peptidase.
Claim 2
Dependent Claim 199 words
A peptide-lipid conjugate having the formula: ##STR6## wherein: X is a linker selected from the group consisting of a single bond and the group R 3 ; each of R 1 , R 2 and R 3 is --OC(O)(CH 2 ) n1 (CH═CH) n2 (CH 2 ) n3 (CH═CH) n4 (CH 2 ) n5 (CH═CH) n6 (CH 2 ) n7 (CH═CH) n8 (CH 2 ) n9 CH 3 ; n1 is zero or an integer equal to from 1 to 22, n3 is zero or an integer equal to from 1 to 19, n5 is zero or an integer equal to from 1 to 16, n7 is zero or an integer equal to from 1 to 13, n9 is zero or an integer equal to from 1 to 10; for each of R 1 and R 2 the sum of n1+2n2+n3+2n4+n5+2n6+n7+2n8+n9 is an integer equal to from 12 to 22; for R 3 the sum of n1+2n2+n3+2n4+n5+2n6+n7+2n8+n9 is an integer equal to from 0 to 22, each of n2, n4, n6 and n8 is equal to 0 or 1; and, Y is an enzyme cleavable peptide comprising an amino acid sequence which is the substrate of a cell-secreted peptidase.
Claim 3
Dependent Claim 11 words
The conjugate of claim 1, wherein X is a single bond.
Claim 4
Dependent Claim 29 words
The conjugate of claim 1, wherein for each of R 1 and R 2 at least one of n2, n4, n6 and n8 is an integer equal to 1.
Claim 5
Dependent Claim 25 words
The conjugate of claim 3, wherein each of R 1 and R 2 is --OC(O)(CH 2 ) 7 (CH═CH)(CH 2 ) 7 CH 3 .
Claim 6
Dependent Claim 16 words
The conjugate of claim 1, wherein the enzyme cleavable peptide comprises the amino acid sequence Ala-Ala.
Claim 7
Dependent Claim 62 words
The conjugate of claim 5, wherein the enzyme cleavable peptide comprises an amino acid sequence selected from the group consisting of the sequences Ala-Ala-, Ala-Ala-Pro-Val (SEQ ID NO:1), Ala-Ala-Met-, Ala-Ala-Pro-Phe- (SEQ ID NO:3), Ala-Ala-Pro-Met- (SEQ ID NO:4), Ala-Ala-Arg, Ser-Ala-Ala-Arg- (SEQ ID NO:5), Ser-Ser-Ala-Ala-Arg- (SEQ ID NO:6), Ser-S carboxyl sugar-Ala-Ala-Arg- (SEQ ID NO:7), Ala-Ala-Asp-, Ser-Ala-Ala-Asp- (SEQ ID NO:8) and Ser-Ser-Ala-Ala-Asp- (SEQ ID NO:9).
Claim 8
Dependent Claim 19 words
The conjugate of claim 6, wherein the enzyme cleavable peptide comprises the amino acid sequence Ala-Ala-Pro-Val (SEQ ID NO:1).
Claim 9
Dependent Claim 58 words
The conjugate of claim 1, wherein the enzyme cleavable peptide comprises an amino acid sequence selected from the group consisting of the sequences Arg-Pro-Lys-Pro-Leu-Ala-Nva- (SEQ ID NO:10), Ser-Arg-Pro-Lys-Pro-Leu-Ala-Nva- (SEQ ID NO:11), Ser-Ser-Arg-Pro-Lys-Pro-Leu-Ala-Nva (SEQ ID NO:12), Pro-Cha-Gly-Nva-His-Ala-Dpa-NH 2 (SEQ ID NO:13), Pro-Leu-Gly-Leu-Dpa-Ala-Arg-NH 2 (SEQ ID NO:14), Pro-Cha-Gly-Nva-, Pro-Leu-Gly-Leu- (SEQ ID NO:15), Gly-Pro-Arg, Leu-Pro-Arg, Glu-Gly-Arg and Gly-Pro-Gln-Gly-Ile- (SEQ ID NO:16).
Claim 10
Dependent Claim 36 words
The conjugate of claim 1, wherein the enzyme cleavable peptide is modified at its amino terminus by a moiety selected from the group consisting of acetyl, methoxy, carboxy sugar polyethylene glycol and methoxy-substituted carboxy sugar modifications.
Claim 11
Dependent Claim 14 words
The conjugate of claim 9, wherein the amino-terminal modification is by a methoxy-succinyl moiety.
Claim 12
Dependent Claim 20 words
The conjugate of claim 10, wherein the enzyme cleavable peptide comprises the modified amino acid sequence N-methoxy-succinyl-Ala-Ala-Pro-Val (SEQ ID NO:2).
Claim 13
Dependent Claim 8 words
The conjugate of claim 1 which is ##STR7##

References Cited (Backward Citations)

US4837028A Cited
US4920016A Cited
US5013556A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 2003-07-11 2004-01-10 2004-07-11 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 2007-07-11 2008-01-10 2008-07-11 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 2011-07-11 2012-01-10 2012-07-11 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag